Patents by Inventor Jennifer Albaneze-Walker

Jennifer Albaneze-Walker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11040953
    Abstract: Disclosed are processes and intermediates for the preparation of compound (X), which is currently being investigated for the treatment of prostate cancer.
    Type: Grant
    Filed: July 27, 2020
    Date of Patent: June 22, 2021
    Assignee: Aragon Pharmaceuticals, Inc.
    Inventors: Cyril Ben Haim, Andras Horvath, Johan Erwin Edmond Weerts, Jennifer Albaneze-Walker
  • Publication number: 20200354334
    Abstract: Disclosed are processes and intermediates for the preparation of compound (X), which is currently being investigated for the treatment of prostate cancer.
    Type: Application
    Filed: July 27, 2020
    Publication date: November 12, 2020
    Inventors: Cyril Ben Haim, Andras Horvath, Johan Erwin Edmond Weerts, Jennifer Albaneze-Walker
  • Patent number: 10723714
    Abstract: Disclosed are processes and intermediates for the preparation of compound (X), which is currently being investigated for the treatment of prostate cancer.
    Type: Grant
    Filed: May 31, 2019
    Date of Patent: July 28, 2020
    Assignee: Aragon Pharmaceuticals, Inc.
    Inventors: Cyril Ben Haim, Andras Horvath, Johan Erwin Edmond Weerts, Jennifer Albaneze-Walker
  • Publication number: 20190284156
    Abstract: Disclosed are processes and intermediates for the preparation of compound (X), which is currently being investigated for the treatment of prostate cancer.
    Type: Application
    Filed: May 31, 2019
    Publication date: September 19, 2019
    Inventors: Cyril Ben Haim, Andras Horvath, Johan Erwin Edmond Weerts, Jennifer Albaneze-Walker
  • Patent number: 10316015
    Abstract: Disclosed are processes and intermediates for the preparation of compound (X), which is currently being investigated for the treatment of prostate cancer.
    Type: Grant
    Filed: December 17, 2015
    Date of Patent: June 11, 2019
    Assignee: Aragon Pharmaceuticals, Inc.
    Inventors: Cyril Ben Haim, Andras Horvath, Johan Erwin Edmond Weerts, Jennifer Albaneze-Walker
  • Publication number: 20190135775
    Abstract: Disclosed are processes and intermediates for the preparation of compound (X), which is currently being investigated for the treatment of prostate cancer.
    Type: Application
    Filed: December 17, 2015
    Publication date: May 9, 2019
    Inventors: Cyril Ben Haim, Andras Horvath, Johan Erwin Edmond Weerts, Jennifer Albaneze-Walker
  • Publication number: 20180002309
    Abstract: Disclosed are processes and intermediates for the preparation of compound (X), which is currently being investigated for the treatment of prostate cancer.
    Type: Application
    Filed: December 17, 2015
    Publication date: January 4, 2018
    Inventors: Cyril Ben Haim, Andras Horvath, Johan Erwin Edmond, Jennifer Albaneze-Walker
  • Publication number: 20170165287
    Abstract: Provided are crystalline forms of the compound of formula (I), which is a nucleoside inhibitor of HCV, processes for the preparation thereof, and pharmaceutical compositions comprising these crystalline forms.
    Type: Application
    Filed: November 28, 2013
    Publication date: June 15, 2017
    Inventors: Jennifer ALBANEZE-WALKER, Xianglu ZENG, Yuanyuan YUAN
  • Publication number: 20160176844
    Abstract: Disclosed are processes and intermediates for the preparation of compound (X), which is currently being investigated for the treatment of prostate cancer.
    Type: Application
    Filed: December 17, 2015
    Publication date: June 23, 2016
    Inventors: Cyril Ben Haim, Andras Horvath, Johan Erwin Edmond, Jennifer Albaneze-Walker
  • Patent number: 8680294
    Abstract: Processes useful for the preparation of a Compound of Formula I: Formula (I). Intermediates useful for the preparation of the compound of Formula I, and processes useful for preparing said intermediates are disclosed.
    Type: Grant
    Filed: July 27, 2010
    Date of Patent: March 25, 2014
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: John Traverse, William M. Leong, Steven P. Miller, Jennifer Albaneze-Walker, Thomas J. Hunter, Lijun Wang, Hongbiao Liao, Ashok Arasappan, Scott T. Trzaska, Randi M. Smith, Azzeddine Lekhal, Stephane L. Bogen, Jianshe Kong, Frank Bennett, F. George Njoroge, Marc Poirier, Shen-Chun Kuo, Yonggang Chen, Kenneth S. Matthews, Patrice Demonchaux, Amadeo Ferreira
  • Publication number: 20120178942
    Abstract: Processes useful for the preparation of a Compound of Formula I: Formula (I). Intermediates useful for the preparation of the compound of Formula I, and processes useful for preparing said intermediates are disclosed.
    Type: Application
    Filed: July 27, 2010
    Publication date: July 12, 2012
    Inventors: John Traverse, William M. Leong, Steven P. Miller, Jennifer Albaneze-Walker, Thomas J. Hunter, Lijun Wang, Hongbiao Liao, Ashok Arasappan, Scott T. Trzaska, Randi M. Smith, Azzeddine Lekhal, Stephane L. Bogen, Jianshe Kong, Frank Bennett, F. George Njoroge, Marc Poirier, Shen-Chun Kuo, Yonggang Chen, Kenneth S. Matthews, Patrice Demonchaux, Amadeo Ferreira
  • Patent number: 7312334
    Abstract: In one aspect, the present invention is directed to a one pot method of preparing intermediates of Formula (V), which are useful in making inhibitors of phosphodiesterase-4: The present invention is also directed to a method of preparing phosphodiesterase inhibitors comprising the Formula (IX, IXa).
    Type: Grant
    Filed: November 18, 2003
    Date of Patent: December 25, 2007
    Assignee: Merck & Co. Inc.
    Inventors: Jennifer Albaneze-Walker, Jerry Anthony Murry, Arash Soheili, Shawn A. Springfield
  • Publication number: 20060019981
    Abstract: In one aspect, the present invention is directed to a one pot method of preparing intermediates of Formula (V), which are useful in making inhibitors of phosphodiesterase-4: The present invention is also directed to a method of preparing phosphodiesterase inhibitors comprising the Formula (IX, IXa)
    Type: Application
    Filed: November 18, 2003
    Publication date: January 26, 2006
    Inventors: Jennifer Albaneze-Walker, Jerry Murry, Arash Soheili, Shawn Springfield
  • Patent number: 6909002
    Abstract: In one aspect, the present invention is directed to a one pot method of preparing intermediates of Formula V, which are useful in making inhibitors of phosphodiesterase-4: The present invention is also directed to a method of preparing phosphodiesterase inhibitors comprising the Formula
    Type: Grant
    Filed: October 21, 2003
    Date of Patent: June 21, 2005
    Assignee: Merck & Co., Inc.
    Inventors: Jennifer Albaneze-Walker, Scott Ceglia, Jerry Anthony Murry, Arash Soheili
  • Publication number: 20040102472
    Abstract: In one aspect, the present invention is directed to a one pot method of preparing intermediates of Formula V, which are useful in making inhibitors of phosphodiesterase-4: 1
    Type: Application
    Filed: October 21, 2003
    Publication date: May 27, 2004
    Inventors: Jennifer Albaneze-Walker, Scott Ceglia, Jerry Anthony Murry, Arash Soheili